Myriad Genetics
MYGN
MYGN
186 hedge funds and large institutions have $1.33B invested in Myriad Genetics in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 69 increasing their positions, 72 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
186
Holders Change
-2
Holders Change %
-1.06%
% of All Funds
2.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
69
Reduced
72
Closed
17
Calls
$6.9M
Puts
$261K
Net Calls
+$6.64M
Net Calls Change
-$9.4M
Top Buyers
| 1 |
Millennium Management
New York
|
+$41.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$10.2M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$4.03M |
| 4 |
EARNEST Partners
Atlanta,
Georgia
|
+$3.52M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.42M |
Top Sellers
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$18.5M |
| 2 |
BlackRock
New York
|
-$7.66M |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$5.51M |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$3.85M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$3.11M |
